Institute for International Research

CNS Featured Sessions

Minimize Placebo Response to Reduce Trial Failure and Conserve Resources
Ramana Kuchibhatla, Sr. Director, Clinical Development, Biostatistics, and Data Management
TARGACEPT

Conquering the Challenge: Working with Highly Vulnerable Patients in Emerging Markets
Margaretta Nyilas, Global Development & Commercialization and Director Global Medical Science,
OTSUKA AMERICA PHARMACEUTICALS

7 Reasons Why this is THE Must Attend CNS Clinical Trial Event:
1. Improve the Outcome of your Trial Through Ethical Consent and Patient Care with the Cleveland Clinic Foundation
2. Minimize the Placebo Effect and Maximize Trial Success with Targacept
3. Tackle the Regulatory Challenges in CNS to Expedite Drug Approval with CATO Research
4. Best Practices for Standardized Rating Scales to Increase Objectivity with the Belmont Center for Comprehensive Treatment
5. Improve Your Ability to Predict Clinical Outcomes with Pre-Clinical and Behavioral Models with Wyeth Research
6. Receive First Hand Expertise on Conducting a Pediatric Psychiatric International Clinical Trial with Otsuka Pharmaceuticals
7. Simplify the Arduous Process of Recruiting & Retaining Treatment Naïve Patients with Pivotal Research Centers

More Interactivity & Shared Learning Makes this a Guaranteed Do Not Miss!

• In-Depth Interactive Inclusive Workshop on Utilizing Adaptive Trial Design to Produce Higher Quality Data with Fewer Patients
• Co-located with Partnerships with CROs Offering Over 1,800 Clinical Professionals to Network With!